ReviewMolecular medicine (Cambridge, Mass.)2024

Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy.

Fengzhao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.